Discovery of predictive biomarkers in malignant gliomas

Autor Holdhoff, Matthias
Vydáno v Neuro Oncol (2019)

Controversies in the Adjuvant Therapy of High-Grade Gliomas

Autor Holdhoff, Matthias, Grossman, Stuart A.
Vydáno 2011

Emerging methods for disease monitoring in malignant gliomas

Autor Ambady, Prakash, Bettegowda, Chetan, Holdhoff, Matthias
Vydáno v CNS Oncol (2013)

Glioblastoma in older adults

Autor Holdhoff, Matthias, Rothenberger, Raphael, Browner, Ilene E.
Vydáno v Aging (Albany NY) (2018)

Systemic Approach to Recurrent Primary CNS Lymphoma: Perspective on Current and Emerging Treatment Strategies

Autor Holdhoff, Matthias, Wagner-Johnston, Nina, Roschewski, Mark
Vydáno v Onco Targets Ther (2020)

Actionable molecular biomarkers in primary brain tumors

Autor Staedtke, Verena, Dzaye, Omar Dildar a, Holdhoff, Matthias
Vydáno v Trends Cancer (2016)

Systemic use of tumor necrosis factor alpha as an anticancer agent

Autor Roberts, Nicholas J., Zhou, Shibin, Diaz, Luis A., Holdhoff, Matthias
Vydáno 2011

Blood-based biomarkers for malignant gliomas

Autor Holdhoff, Matthias, Yovino, Susannah G., Boadu, Osei, Grossman, Stuart A.
Vydáno 2013

Persistent Positron Emission Tomography–Positive Liver Lesions After Successful Chemotherapy in Mediastinal Seminoma

Autor Holdhoff, Matthias, Wung, Peter K., Petronis, John D., Couzi, Rima
Vydáno 2007

‘Elderly’ patients with newly diagnosed glioblastoma deserve optimal care

Autor Holdhoff, Matthias, Rosner, Gary L., Alcorn, Sara, Grossman, Stuart A.
Vydáno 2013

PATH-35. FREQUENCY AND CHARACTERISTICS OF H3K27M-MUTATION IN ADULTS WITH RADIOGRAPHICALLY-DETERMINED MIDLINE GLIOMAS

Autor Schreck, Karisa, Ranjan, Surabhi, Skorupan, Nebojsa, Ames, Heather, Holdhoff, Matthias
Vydáno v Neuro Oncol (2018)

Late relapses in primary CNS lymphoma after complete remissions with high-dose methotrexate monotherapy

Autor Ambady, Prakash, Holdhoff, Matthias, Bonekamp, David, Wong, Fay, Grossman, Stuart A
Vydáno v CNS Oncol (2015)

HOUT-22. PATTERN OF BEVACIZUMAB USE IN PATIENTS WITH GLIOBLASTOMA AT NATIONAL CANCER INSTITUTE-DESIGNATED CANCER CENTERS IN 2017

Autor Ranjan, Surabhi, Skorupan, Nebojsa, Ye, Xiaobu, Yankulina, Olga, Grossman, Stuart A, Holdhoff, Matthias
Vydáno v Neuro Oncol (2017)

INNV-28. TEMOZOLOMIDE IN RENAL DYSFUNCTION

Autor Garzio, Kayla, McElroy, Kelly, Grossman, Stuart, Holdhoff, Matthias, Ozer, Byram, Yankulina, Olga
Vydáno v Neuro Oncol (2020)

AT-27 CHALLENGES OF RETROSPECTIVELY DETERMINING THE EQUIVALENCE OF PCV VERSUS TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED 1p/19q CO-DELETED ANAPLASTIC OLIGODENDROGLIOMAS

Autor Jain, Rohit, Abdelaziz, Ahmed, Blakeley, Jaishri O., Ye, Xiaobu, Grossman, Stuart A., Holdhoff, Matthias
Vydáno 2014

Ipilimumab-Induced Enteritis without Colitis: A New Challenge

Autor Messmer, Marcus, Upreti, Sunita, Tarabishy, Yaman, Mazumder, Nikhilesh, Chowdhury, Reezwana, Yarchoan, Mark, Holdhoff, Matthias
Vydáno v Case Rep Oncol (2016)

Pneumocystis jirovecii prophylaxis in patients treated for high-grade gliomas: a survey among neuro-oncologists

Autor Skorupan, Nebojša, Ranjan, Surabhi, Mehta, Seema, Yankulina, Olga, Nenortas, Nathan, Grossman, Stuart, Ye, Xiaobu, Holdhoff, Matthias
Vydáno v Neurooncol Pract (2019)

ACTR-63. PHASE I DOSE ESCALATION STUDY OF PROCASPASE ACTIVATING COMPOUND-1 (PAC-1) IN COMBINATION WITH TEMOZOLOMIDE IN PATIENTS WITH RECURRENT ANAPLASTIC ASTROCYTOMA OR GLIOBLASTOM...

Autor Holdhoff, Matthias, Nicholas, Martin, Peterson, Richard, Danciu, Oana, Maraka, Stefania, Hergenrother, Paul, Tarasow, Theodore, Dudek, Arkadiusz
Vydáno v Neuro Oncol (2019)

High-dose methotrexate with or without rituximab in newly diagnosed primary CNS lymphoma

Autor Holdhoff, Matthias, Ambady, Prakash, Abdelaziz, Ahmed, Sarai, Guneet, Bonekamp, David, Blakeley, Jaishri, Grossman, Stuart A., Ye, Xiaobu
Vydáno 2014

ACTR-06. INITIAL RESULTS OF A PHASE I STUDY OF PROCASPASE ACTIVATING CCOMPOUND-1 (PAC-1) IN COMBINATION WITH TEMOZOLOMIDE FOR RECURRENT MALIGNANT GLIOMA

Autor Nicholas, Martin, Holdhoff, Matthias, Peterson, Richard, Danciu, Oana, Wefel, Jeffrey, Tarasow, Ted, Hergenrother, Paul J, Dudek, Arkadiussz
Vydáno v Neuro Oncol (2018)